Aoxing Pharmaceutical Company, Inc.
AOXG · OTC
6/30/2025 | 6/30/2024 | 6/30/2016 | 6/30/2015 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | – | $7 | $5 |
| Short-Term Investments | – | – | $0 | $0 |
| Receivables | – | – | $11 | $6 |
| Inventory | – | – | $3 | $3 |
| Other Curr. Assets | – | – | $6 | $7 |
| Total Curr. Assets | – | – | $27 | $21 |
| Property Plant & Equip (Net) | – | – | $26 | $29 |
| Goodwill | – | – | $0 | $0 |
| Intangibles | – | – | $2 | $0 |
| Long-Term Investments | – | – | $0 | $0 |
| Tax Assets | – | – | $2 | $3 |
| Other NC Assets | – | – | $0 | $0 |
| Total NC Assets | – | – | $29 | $32 |
| Other Assets | – | – | $0 | $0 |
| Total Assets | – | – | $56 | $53 |
| Liabilities | – | – | – | – |
| Payables | – | – | $3 | $4 |
| Short-Term Debt | – | – | $25 | $30 |
| Tax Payable | – | – | $3 | $1 |
| Deferred Revenue | – | – | $0 | $0 |
| Other Curr. Liab. | – | – | $7 | $6 |
| Total Curr. Liab. | – | – | $38 | $41 |
| LT Debt | – | – | $0 | $1 |
| Deferred Rev, NC | – | – | $0 | $0 |
| Deferred Tax Liab, NC | – | – | $0 | -$0 |
| Other NC Liab. | – | – | $0 | $0 |
| Total NC Liab. | – | – | $0 | $2 |
| Other Liabilities | – | – | $0 | $0 |
| Cap. Leases | – | – | $0 | $0 |
| Total Liabilities | – | – | $38 | $43 |
| Equity | – | – | – | – |
| Pref Stock | – | – | $0 | $0 |
| Common Stock | – | – | $0 | $0 |
| Retained Earnings | – | – | -$56 | -$58 |
| AOCI | – | – | $2 | $3 |
| Other Equity | – | – | $74 | $66 |
| Total Equity | – | – | $19 | $11 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | – | -$1 | -$1 |
| Total Liab. & Tot. Equity | – | – | $56 | $53 |
| Net Debt | $0 | $0 | $19 | $26 |